Health Condition 1: F400- Agoraphobia Health Condition 2: F411- Generalized anxiety disorder Health Condition 3: F413- Other mixed anxiety disorders Health Condition 4: F418- Other specified anxiety disorders Health Condition 5: F410- Panic disorder [episodic paroxysmal anxiety] Health Condition 6: F401- Social phobias
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with a primary diagnosis of anxiety disorder according to DSM-V People who consent for the baseline phase Patients who can comprehend and be conversant in English, Tamil or Malayalam Stabilized on medication 4 weeks prior to the beginning of the therapy
Exclusion criteria
Exclusion criteria: Primary diagnosis of schizophrenia, bipolar affective disorder, patients with suicidal risk, co-morbid severe depression with or without psychotic symptoms and clinical evidence for intellectual disability, or other neurological, neurosurgical or organic conditions that may interfere with engagement in therapy Current use of psychoactive substance in dependence pattern except nicotine dependence Primary diagnosis of depression with secondary anxiety symptoms Patients who have undergone structured psychotherapeutic intervention of 8 or more sessions will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: symptom severity (anxiety) Secondary outcome: anxiety sensitivity, intolerance to uncertainty, emotion regulationTimepoint: Primary outcome: Weekly assessment Secondary Outcome: Module wise assessment (approximately 2-4 sessions once) | — |
Secondary
| Measure | Time frame |
|---|---|
| anxiety sensitivity, intolerance to uncertainty, emotion regulationTimepoint: pre-treatment, module-wise assessment, post treatment and follow-up | — |
Countries
India
Contacts
National Institute of Mental Health and Neuro Sciences